These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045 [TBL] [Abstract][Full Text] [Related]
51. FDG PET imaging in patients with pathologically verified dementia. Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505 [TBL] [Abstract][Full Text] [Related]
52. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism. Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913 [TBL] [Abstract][Full Text] [Related]
53. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189 [TBL] [Abstract][Full Text] [Related]
54. 18F-FDG and 18F-florbetapir PET in clinical practice: regional analysis in mild cognitive impairment and Alzheimer disease. Bailly M; Ribeiro MJ; Vercouillie J; Hommet C; Gissot V; Camus V; Guilloteau D Clin Nucl Med; 2015 Feb; 40(2):e111-6. PubMed ID: 25549345 [TBL] [Abstract][Full Text] [Related]
55. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550 [TBL] [Abstract][Full Text] [Related]
56. Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI. Ben Bouallègue F; Mariano-Goulart D; Payoux P; J Alzheimers Dis; 2018; 62(1):399-408. PubMed ID: 29439345 [TBL] [Abstract][Full Text] [Related]
57. Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia. Mosconi L; Andrews RD; Matthews DC J Alzheimers Dis; 2013; 35(3):509-24. PubMed ID: 23478305 [TBL] [Abstract][Full Text] [Related]
58. Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET study. Babiloni C; Del Percio C; Caroli A; Salvatore E; Nicolai E; Marzano N; Lizio R; Cavedo E; Landau S; Chen K; Jagust W; Reiman E; Tedeschi G; Montella P; De Stefano M; Gesualdo L; Frisoni GB; Soricelli A Neurobiol Aging; 2016 Dec; 48():122-134. PubMed ID: 27668356 [TBL] [Abstract][Full Text] [Related]
59. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. Meltzer CC; Leal JP; Mayberg HS; Wagner HN; Frost JJ J Comput Assist Tomogr; 1990; 14(4):561-70. PubMed ID: 2370355 [TBL] [Abstract][Full Text] [Related]
60. Neural correlates of the Clock Drawing Test performance in Alzheimer's disease: a FDG-PET study. Lee DY; Seo EH; Choo IH; Kim SG; Lee JS; Lee DS; Jhoo JH; Kim KW; Youn JC; Woo JI Dement Geriatr Cogn Disord; 2008; 26(4):306-13. PubMed ID: 18841015 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]